Correlation Between Protokinetix and RespireRx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protokinetix and RespireRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protokinetix and RespireRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protokinetix and RespireRx Pharmaceuticals, you can compare the effects of market volatilities on Protokinetix and RespireRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protokinetix with a short position of RespireRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protokinetix and RespireRx Pharmaceuticals.

Diversification Opportunities for Protokinetix and RespireRx Pharmaceuticals

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Protokinetix and RespireRx is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Protokinetix and RespireRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RespireRx Pharmaceuticals and Protokinetix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protokinetix are associated (or correlated) with RespireRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RespireRx Pharmaceuticals has no effect on the direction of Protokinetix i.e., Protokinetix and RespireRx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Protokinetix and RespireRx Pharmaceuticals

If you would invest  1.22  in Protokinetix on September 4, 2024 and sell it today you would lose (0.32) from holding Protokinetix or give up 26.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

Protokinetix  vs.  RespireRx Pharmaceuticals

 Performance 
       Timeline  
Protokinetix 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Protokinetix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Protokinetix showed solid returns over the last few months and may actually be approaching a breakup point.
RespireRx Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RespireRx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, RespireRx Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Protokinetix and RespireRx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protokinetix and RespireRx Pharmaceuticals

The main advantage of trading using opposite Protokinetix and RespireRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protokinetix position performs unexpectedly, RespireRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RespireRx Pharmaceuticals will offset losses from the drop in RespireRx Pharmaceuticals' long position.
The idea behind Protokinetix and RespireRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk